Dr. Reddys Labs (RDY) Announces U.S. Launch of Generic Nitrostat Tabs
Tweet Send to a Friend
Dr. Reddy’s Laboratories Ltd (NYSE: RDY) announced that it has launched Nitroglycerin sublingual tablets USP, 0.3 mg, 0.4 mg and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
